Clinical trial NCT05192746: Radial Extracorporeal Shock Wave Therapy Versus High Power Pain Threshold Ultrasound Therapy in Supraspinatus Tendinitis
Official title: Radial Extracorporeal Shock Wave Therapy Versus High Power Pain Threshold Ultrasound Therapy on Pain,Pressure Threshold Supraspinatus Trigger Point
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Supraspinatus Tendinitis
Keywords: extracorporeal shock wave
high power pain threshold ultrasound
Lead sponsor: Cairo University
Sponsor class: OTHER
First posted: 2022-01-14
Enrollment: 66
Sex: ALL
Minimum age (years): 30
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: pre post intervention study
Primary purpose: TREATMENT

Brief summary: Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.High power pain threshold ultrasound is the use of therapeutic ultrasound in a continuous mode; with the probe placed directly on affected area (supraspinatus tendon)

Detailed description: Shock wave therapy is an effective method of dissolving calcification and stimulating tissue healing. Extra corporeal shock wave therapy is a treatment method in which high-amplitude sound waves are focused on the targeted body tissue Recently, Extra corporeal shock wave therapy has been proposed as an alternative treatment in patients not responding to pharmaceutical treatment.US have been widely used for more than 40 years in the treatment of musculoskeletal disorders such as tendinitis, tenosynovitis, epicondylitis, bursitis and osteoarthritis. High power pain threshold ultrasound is the use of therapeutic ultrasound in a continuous mode; with the probe placed directly on affected area (supraspinatus tendon) "the intensity of ultrasound is first increased to the threshold pain level (to 1.5 W/cm) and then reduced to one half of that intensity. It was kept at that level for 4 to 5 seconds and then reduced to the half-intensity level for another 15 seconds .

Eligibility criteria: Inclusion Criteria:

* Patients' age ranges from 30 to 50 years old.
* Patients are males and females.
* BMI of all subjects were \<30 Kg/m2.
* Patients will be diagnosed as supraspinatus tendinitis.
* All patients are medically stable.
* All patients should be conscious and ambulant.
* Patients don't have any nervous system problems
* Patients don't have shoulder disorder other than tendenities
* Patients that didn't undergo any surgery in shoulder joint

Exclusion Criteria:

* • Patients who received intra articular injection from duration less than 3 months.

  * Patients with supraspinatus tendonitis secondary to trauma.
  * Patients with metal implants.
  * Patient who had malignancy in the affected area.
  * Patient with acute infection in the treated area.
  * Diabetic patients
  * Bone infection
  * Shoulder instability
  * Epilepsy
  * Coagulation diseases
  * Rheumatological diseases (rheumatoid arthritis and gouty arthritis)

Primary outcomes:
measure: 1. pain intensity[Time Frame:]
timeFrame: up to four weeks
measure: 2.range of motion
timeFrame: up to four weeks
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
References: